1 |
Avey et al.36
|
mouse |
neurons |
morphine |
8,138 |
mock-treated 8,912; morphine-treated, 7,972 |
56 |
opioid signaling; signaling by G-protein-coupled receptors; reduction of cytosolic calcium levels; morphine addiction |
2 |
Kagohara et al.48
|
human |
carcinoma cell line |
cetuximab |
11,140 |
untreated, 5,217; treated, 4,507 |
125 |
EGFR1 pathway; regulation of apoptosis; cell-cycle checkpoints; G1 cell-cycle arrest, regulation of apoptosis |
3 |
Little et al.54
|
mouse |
lung alveolar cells |
Nkx2-1 gene KO |
7,842 |
WT, 638; KO, 2,397 |
29 |
gastrointestinal marker genes; Sox2 target genes |
4 |
Hagai et al.58
|
human |
dermal fibroblasts |
dsRNA immune stimulus |
7,904 |
unstimulated, 2,553; stimulated, 2,130 |
29 |
interferon signaling; immune system; interleukin-1 regulation of extracellular matrix |
5 |
Zhou et al.64
|
mouse |
neurons |
Alzheimer disease |
2,869 |
WT, 4,561; 5xFAD, 2,423 |
18 |
Apoe and Bin1; regulation of neuron projection development; positive regulation of cell projection organization; phosphatidylserine metabolic process; protein acylation; potassium channel activity; methylation-dependent protein binding; integrin signaling pathway; serotonin HTR1 group and FOS pathway; glutamate neurotransmitter release cycle |